SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-001224
Filing Date
2024-02-07
Accepted
2024-02-07 15:01:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 SELLAS LIFE SCIENCES GROUP, INC. p24-0661sc13g.htm SC 13G 49921
  Complete submission text file 0000902664-24-001224.txt   52004
Mailing Address 277 PARK AVE 23RD FLOOR NEW YORK NY 10172
Business Address 277 PARK AVE 23RD FLOOR NEW YORK NY 10172 2122872500
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000919185 (see all company filings)

IRS No.: 134131516 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Subject) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-84090 | Film No.: 24603935
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)